VX-708

DRUG2 trials

Sponsors

Vertex Pharmaceuticals Incorporated

Conditions

Acute PainPain

Phase 1

A Phase 1 Dose Escalation Study of Oral VX-708 in Healthy Participants

CompletedNCT05347394

Vertex Pharmaceuticals IncorporatedAcute Pain

Start: 2022-04-08End: 2023-04-14Updated: 2023-05-15

A Phase 1 Dose Escalation Study of VX-708 in Healthy Participants

CompletedNCT05518734

Vertex Pharmaceuticals IncorporatedPain

Start: 2022-09-17End: 2023-03-07Updated: 2023-03-30